What is he best known for?
The fields of study he is best known for:
- Neurotransmitter
- Gene
- Dopamine
His main research concerns Neuroscience, Dopamine, Pharmacology, Addiction and Inhibitory postsynaptic potential.
His research in Neuroscience intersects with topics in Neurotransmission and Cannabinoid receptor.
His work in Cannabinoid receptor addresses issues such as GABAB receptor, which are connected to fields such as Voltage-dependent calcium channel.
His research in Dopamine is mostly concerned with Dopaminergic.
In the subject of general Pharmacology, his work in Designer drug is often linked to Pyrovalerone, thereby combining diverse domains of study.
His studies in Nucleus accumbens integrate themes in fields like Cannabinoid and Long-term depression.
His most cited work include:
- It could be habit forming: drugs of abuse and striatal synaptic plasticity. (420 citations)
- Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. (362 citations)
- Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. (292 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Neuroscience, Dopamine, Internal medicine, Endocrinology and Cannabinoid receptor.
Carl R. Lupica has researched Neuroscience in several fields, including Synaptic plasticity, Glutamate receptor and Neurotransmission.
His Dopamine course of study focuses on Cell biology and Secretion.
Carl R. Lupica focuses mostly in the field of Endocrinology, narrowing it down to topics relating to Agonist and, in certain cases, GABAA receptor, Schaffer collateral and Antagonist.
His Cannabinoid receptor study combines topics in areas such as Hippocampus, Cannabinoid and Pharmacology.
His Pharmacology study incorporates themes from Adenosine, Cannabinoid receptor antagonist, Adenosine A1 receptor, Adenosine receptor and Cannabinoid Receptor Agonists.
He most often published in these fields:
- Neuroscience (56.88%)
- Dopamine (26.61%)
- Internal medicine (25.69%)
What were the highlights of his more recent work (between 2016-2021)?
- Neuroscience (56.88%)
- Cannabinoid (23.85%)
- Cannabinoid receptor (23.85%)
In recent papers he was focusing on the following fields of study:
Carl R. Lupica spends much of his time researching Neuroscience, Cannabinoid, Cannabinoid receptor, Endocannabinoid system and Cannabis.
His work on Addiction, Dopamine, Optogenetics and Excitatory postsynaptic potential as part of general Neuroscience research is frequently linked to Context, bridging the gap between disciplines.
His Addiction study combines topics from a wide range of disciplines, such as Habenula and Cholinergic.
His study focuses on the intersection of Cannabinoid receptor and fields such as Synaptic plasticity with connections in the field of Hippocampus, Neuroplasticity, Postsynaptic potential, Central nervous system and Neurotransmission.
In his study, Secretion, Sigma-1 receptor and Ventral tegmental area is strongly linked to Cell biology, which falls under the umbrella field of Endocannabinoid system.
His Synthetic cannabinoids study deals with Pharmacology intersecting with Allosteric regulation, Indole test and Human brain.
Between 2016 and 2021, his most popular works were:
- Optogenetic silencing of a corticotropin-releasing factor pathway from the central amygdala to the bed nucleus of the stria terminalis disrupts sustained fear. (51 citations)
- Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain (35 citations)
- CYP3A5 Mediates Effects of Cocaine on Human Neocorticogenesis: Studies using an In Vitro 3D Self-Organized hPSC Model with a Single Cortex-Like Unit (34 citations)
In his most recent research, the most cited papers focused on:
- Neurotransmitter
- Gene
- Neuron
His primary areas of investigation include Neuroscience, Optogenetics, Context, Monoaminergic and Cannabinoid.
Neuroscience is closely attributed to Pharmacology in his research.
The study incorporates disciplines such as Corticotropin-releasing hormone, Thalamus, Septal nuclei, Central nucleus of the amygdala and Stria terminalis in addition to Optogenetics.
His Monoaminergic research integrates issues from Cholinergic, Self-administration, Muscimol, Habenula and Addiction.
His work deals with themes such as Baclofen and GABAergic, which intersect with Addiction.
His research in Cannabinoid focuses on subjects like Hippocampal formation, which are connected to Synaptic plasticity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
